JP5548875B2 - 抗真菌剤 - Google Patents

抗真菌剤 Download PDF

Info

Publication number
JP5548875B2
JP5548875B2 JP2011522975A JP2011522975A JP5548875B2 JP 5548875 B2 JP5548875 B2 JP 5548875B2 JP 2011522975 A JP2011522975 A JP 2011522975A JP 2011522975 A JP2011522975 A JP 2011522975A JP 5548875 B2 JP5548875 B2 JP 5548875B2
Authority
JP
Japan
Prior art keywords
pyran
dimethylpropyl
phenanthro
propano
dodecahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2011522975A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011530593A5 (cg-RX-API-DMAC7.html
JP2011530593A (ja
Inventor
グリーンリー,マーク,エル.
ウィルケニング,ロバート
アプガー,ジェームズ
スパーベック,ドナルド
ウィルドンジャー,ケネス,ジェームズ
メン,ドンファン
パーカー,ダン,エル.,ジュニア.
パコフスキー,グレゴリー,ジェームス
ハースレイ,ブライアン,ハイド
ママイ,アハメド
ネルソン,キングスレイ
Original Assignee
サイネクシス,インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41669133&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP5548875(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by サイネクシス,インコーポレーテッド filed Critical サイネクシス,インコーポレーテッド
Publication of JP2011530593A publication Critical patent/JP2011530593A/ja
Publication of JP2011530593A5 publication Critical patent/JP2011530593A5/ja
Application granted granted Critical
Publication of JP5548875B2 publication Critical patent/JP5548875B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647Triazoles; Hydrogenated triazoles
    • A01N43/6531,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2011522975A 2008-08-12 2009-08-07 抗真菌剤 Active JP5548875B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13610108P 2008-08-12 2008-08-12
US61/136,101 2008-08-12
PCT/US2009/004560 WO2010019204A1 (en) 2008-08-12 2009-08-07 Antifungal agents

Publications (3)

Publication Number Publication Date
JP2011530593A JP2011530593A (ja) 2011-12-22
JP2011530593A5 JP2011530593A5 (cg-RX-API-DMAC7.html) 2012-12-20
JP5548875B2 true JP5548875B2 (ja) 2014-07-16

Family

ID=41669133

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011522975A Active JP5548875B2 (ja) 2008-08-12 2009-08-07 抗真菌剤

Country Status (7)

Country Link
US (1) US8188085B2 (cg-RX-API-DMAC7.html)
EP (1) EP2326181A4 (cg-RX-API-DMAC7.html)
JP (1) JP5548875B2 (cg-RX-API-DMAC7.html)
CN (2) CN104877001B (cg-RX-API-DMAC7.html)
AU (1) AU2009282474B2 (cg-RX-API-DMAC7.html)
CA (1) CA2731941C (cg-RX-API-DMAC7.html)
WO (1) WO2010019204A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2809219A1 (en) 2010-08-26 2012-03-01 Bayer Intellectual Property Gmbh 5-iodo-triazole derivatives
LT3247711T (lt) * 2015-01-19 2022-05-25 Scynexis, Inc. Naujos scy-078 druskos ir polimorfai
EP3609539A1 (en) * 2017-04-10 2020-02-19 Scynexis, Inc. Antifungal agents used in combination
EP4732902A2 (en) 2017-08-04 2026-04-29 Scynexis, Inc. Antifungal agents with enhanced activity in acidic ph
MA51514A (fr) * 2018-01-02 2021-04-07 Scynexis Inc Compositions injectables d'antifongiques triterpénoïdes encapsulées dans des liposomes
US12053486B2 (en) 2018-03-09 2024-08-06 Therazure LLC Compositions for the treatment of infections in feet
MA54866A (fr) * 2019-01-30 2022-05-04 Scynexis Inc Antifongiques triterpénoïdes pour le traitement d'infections ostéoarticulaires fongiques
MA55081A (fr) 2019-02-27 2022-01-05 Scynexis Inc <smallcaps/>? ? ?pneumocystis? ? ? ? ?antifongiques triterpénoïdes pour le traitement ou la prévention de la pneumonie àspp
BR112021022876A2 (pt) 2019-05-16 2022-04-12 Scynexis Inc Método para descolonizar candida auris de uma área anatômica de um sujeito
WO2021092349A1 (en) 2019-11-08 2021-05-14 Scynexis, Inc. Lipid-based formulations of scy-078 salts
EP4058066A4 (en) * 2019-11-15 2023-12-06 The Research Foundation for The State University of New York ANTIFUNGAL COMPOSITIONS AND METHODS OF USE
CN118724779B (zh) * 2024-06-05 2025-09-23 浙江瑞博制药有限公司 一种醛基化合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997027860A1 (en) 1996-01-31 1997-08-07 Merck & Co., Inc. Antifungal agent
US5756472A (en) 1996-01-31 1998-05-26 Merck & Co., Inc. Antifungal agent obtained from hormonema
HUP0303249A3 (en) 2001-02-22 2007-03-28 Sankyo Co Water-soluble triazole fungicide compounds and pharmaceutical compositions containing them
FR2824324B1 (fr) 2001-05-04 2003-08-15 Aventis Pharma Sa Nouveaux derives d'azole ou de triazole, leur procede de preparation et leur application comme medicaments anti-fongiques
CN1705657A (zh) 2002-04-17 2005-12-07 兰贝克赛实验室有限公司 作为抗真菌剂的吡咯衍生物
DK2007396T3 (da) 2006-04-03 2013-03-18 Merck Sharp & Dohme Enfumafungin-derivat som antimykotika

Also Published As

Publication number Publication date
CN104877001B (zh) 2020-07-03
CN104877001A (zh) 2015-09-02
US8188085B2 (en) 2012-05-29
CN102176827B (zh) 2015-05-20
CA2731941A1 (en) 2010-02-18
WO2010019204A1 (en) 2010-02-18
US20100113439A1 (en) 2010-05-06
AU2009282474B2 (en) 2014-03-20
EP2326181A1 (en) 2011-06-01
CN102176827A (zh) 2011-09-07
JP2011530593A (ja) 2011-12-22
CA2731941C (en) 2016-09-27
AU2009282474A1 (en) 2010-02-18
HK1214271A1 (zh) 2016-07-22
EP2326181A4 (en) 2012-11-28

Similar Documents

Publication Publication Date Title
JP5548875B2 (ja) 抗真菌剤
WO2019141957A1 (en) N-pyrimidinyl hydroxy pyrazole derivatives and uses thereof
EP2326172B1 (en) Antifungal agents
JP5548876B2 (ja) 抗真菌剤
KR20190133251A (ko) 조합하여 사용되는 항진균제
JP7562542B2 (ja) 真菌性骨-関節感染症を治療するためのトリテルペノイド系抗真菌薬
HK1214271B (zh) 抗真菌製劑
HK1158017B (en) Antifungal agents
HK40022879B (en) Antifungal agents used in combination
HK40022879A (en) Antifungal agents used in combination

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120605

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121031

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131211

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140217

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140310

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140409

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140414

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20140421

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140421

R150 Certificate of patent or registration of utility model

Ref document number: 5548875

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250